Leavell Investment Management’s iShares iBonds Dec 2027 Term Treasury ETF IBTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.81M Buy
259,828
+22,261
+9% +$498K 0.21% 121
2026
Q1
$5.33M Buy
237,567
+42,445
+22% +$954K 0.22% 116
2025
Q4
$4.38M Buy
195,122
+38,953
+25% +$876K 0.18% 125
2025
Q3
$3.52M Buy
156,169
+15,349
+11% +$345K 0.15% 149
2025
Q2
$3.17M Buy
140,820
+25,306
+22% +$567K 0.14% 157
2025
Q1
$2.59M Buy
115,514
+6,363
+6% +$142K 0.13% 165
2024
Q4
$2.42M Buy
109,151
+17,043
+19% +$380K 0.12% 172
2024
Q3
$2.08M Buy
92,108
+43,685
+90% +$980K 0.1% 186
2024
Q2
$1.07M Buy
48,423
+18,593
+62% +$408K 0.06% 261
2024
Q1
$661K Buy
29,830
+5,898
+25% +$131K 0.04% 313
2023
Q4
$536K Buy
+23,932
New +$526K 0.03% 319

Other funds holding IBTH

Leavell Investment Management's IBTH Position: Q2 2026 in Review

Leavell Investment Management increased its iShares iBonds Dec 2027 Term Treasury ETF (IBTH) stake by 9.4% in Q2 2026, buying an estimated $498K and bringing the position to 259,828 shares worth $5.81M. The position accounts for 0.21% of the portfolio, ranked #121.

Leavell Investment Management first reported a position in IBTH in Q4 2023 and has held it in 11 quarters since. 310 funds tracked by Wall St. Rank hold IBTH as of Q2 2026.

  • Leavell Investment Management held 259,828 shares of iShares iBonds Dec 2027 Term Treasury ETF worth $5.81M as of Q2 2026.
  • Leavell Investment Management bought 22,261 iShares iBonds Dec 2027 Term Treasury ETF shares in Q2 2026, an estimated $498K.
  • iShares iBonds Dec 2027 Term Treasury ETF made up 0.21% of Leavell Investment Management's portfolio in Q2 2026, its #121 holding.
  • Leavell Investment Management first reported a position in iShares iBonds Dec 2027 Term Treasury ETF in Q4 2023 and has held it in 11 quarters since.
  • 310 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Treasury ETF as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.